Lab Automation In Drug Discovery Global Market Report 2024

Description

Lab automation in drug discovery refers to the utilization of advanced technologies and robotics to streamline and optimize laboratory processes associated with new drug development and research. This approach aims to significantly improve the efficiency and success rate of drug discovery efforts by automating repetitive tasks and integrating sophisticated instruments and software. Automation in drug discovery laboratories can cover a wide range of activities, from high-throughput screening of compounds to data analysis and interpretation, allowing researchers to focus on more complex and creative aspects of their work.

The primary types of lab automation in drug discovery include automated liquid handlers, automated plate handlers, robotic arms, automated storage and retrieval systems, among others. Automated liquid handlers are machines specifically designed to dispense and handle liquids automatically. They are frequently employed in laboratories for precise and efficient liquid handling tasks such as pipetting and dilution. These automation solutions comprise various components, including instruments, software, and services, and find applications in high-throughput screening, compound management, sample preparation, and other processes. These technologies are utilized by various end-users, including biotechnology and pharmaceutical industries, research institutes, and others.

The lab automation in drug discovery research report is one of a series of new reports from The Business Research Company that provides lab automation in drug discovery market statistics, including the lab automation in drug discovery industry's global market size, regional shares, competitors with lab automation in drug discovery market share, detailed lab automation in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation in drug discovery industry. This lab automation in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lab automation in drug discovery market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.47 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The expansion observed in the historical period can be attributed to several factors, including the increasing complexity of drug discovery processes, a demand for improved efficiency and cost reduction, a growing need for high-throughput screening capabilities, rising labor costs, and the pressure to accelerate drug development timelines. These factors collectively contributed to the growth of lab automation in drug discovery during that timeframe.

The lab automation in drug discovery market size is expected to see strong growth in the next few years. It will grow to $7.96 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be attributed to several factors, including the expansion of drug pipelines among pharmaceutical companies, the rise in personalized medicine and precision therapeutics, an increasing focus on rare diseases and orphan drugs, a growing demand for remote and decentralized clinical trials, and the emergence of microfluidics and lab-on-a-chip technologies. Key trends expected in the forecast period include the proliferation of modular and customizable automation solutions, the adoption of cloud-based platforms for data management and collaboration, the growth of automation in emerging markets, the rise of virtual drug discovery companies leveraging automation and digital technologies, and the development of standardized protocols and interoperable systems. These factors collectively contribute to the projected growth in lab automation in drug discovery.

The growing demand for precision medicine is anticipated to drive the growth of lab automation in the drug discovery market. Precision medicine, also known as personalized medicine, tailors medical treatment and prevention strategies based on individual variability in genes, environment, and lifestyle. Lab automation plays a pivotal role in accelerating research, enhancing experimental repeatability, and improving the efficiency of precision medicine and drug discovery procedures. This, in turn, leads to the development of more effective medicines and diagnostics tailored to individual patients. According to the Personalized Medicine Coalition (PMC) in October 2022, over 75,000 genetic testing products and 300 personalized medicines are expected to be available in the market, catering to individuals with various types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. The rising demand for precision medicine is a key driver propelling the growth of lab automation in the drug discovery market.

Prominent companies operating in the lab automation in the drug discovery market are strategically focusing on developing advanced solutions, particularly rapid idea-to-data solutions, to gain a competitive edge. A rapid idea-to-data solution refers to a streamlined process or platform enabling individuals or organizations to quickly transform ideas or concepts into actionable insights or data-driven results. In April 2022, Strateos Inc., a US-based biotechnology company, introduced a rapid idea-to-data solution for small molecule discovery on its cloud lab automation-as-a-service platform. Specifically designed for small-molecule discovery in drug development, this lab automation tool operates on the on-demand and scalable Strateos Cloud Lab Automation-as-a-Service Platform. The platform includes linked robotic automation with 23 workcells and hundreds of instruments, facilitating early lead generation through lead optimization. Users can design compounds in the cloud and have them automatically assembled and tested using various methods such as cell-based, biochemical, and structured-activity relationship (SAR) assessments.

In March 2023, Brooks Automation, a US-based automation solution company, successfully acquired Aim Lab Automation Technologies Pty Ltd. for an undisclosed amount. This strategic acquisition aims to expand Brooks' presence in clinical diagnostics and drive technological advancements, significantly impacting lab automation in the drug discovery market. Aim Lab Automation Technologies Pty Ltd., based in Australia, provides robotic automation instrumentation and modules, along with automation solutions designed to enhance processes in drug discovery labs.

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

North America was the largest region in the lab automation in drug discovery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab automation in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab automation in drug discovery market consists of revenues earned by entities by providing services such as compound screening, assay development, high-throughput screening, data analysis, and optimization of drug candidates. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab automation in drug discovery market also includes sales of robotics and automated workstations, screening systems, plate readers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab Automation In Drug Discovery Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lab automation in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lab automation in drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lab automation in drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Automated Liquid Handlers; Automated Plate Handlers; Robotic Arms; Automated Storage And Retrieval Systems; Other Types
2) By Component: Instruments; Software; Services
3) By Application: High-Throughput Screening; Compound Management; Sample Preparation; Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries; Research Institutes; Other End-Users
Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Diagnostics; Roche Holdings Inc.; Beckman Coulter; Siemens Healthineers
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r17134

1. Executive Summary

2. Lab Automation In Drug Discovery Market Characteristics

3. Lab Automation In Drug Discovery Market Trends And Strategies

4. Lab Automation In Drug Discovery Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Lab Automation In Drug Discovery Market Size and Growth

5.1. Global Lab Automation In Drug Discovery Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Lab Automation In Drug Discovery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Lab Automation In Drug Discovery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lab Automation In Drug Discovery Market Segmentation

6.1. Global Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Automated Liquid Handlers
Automated Plate Handlers
Robotic Arms
Automated Storage And Retrieval Systems
Other Types
6.2. Global Lab Automation In Drug Discovery Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Instruments
Software
Services
6.3. Global Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
High-Throughput Screening
Compound Management
Sample Preparation
Other Applications
6.4. Global Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Biotechnology And Pharmaceutical Industries
Research Institutes
Other End-Users

7. Lab Automation In Drug Discovery Market Regional And Country Analysis

7.1. Global Lab Automation In Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Lab Automation In Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lab Automation In Drug Discovery Market

8.1. Asia-Pacific Lab Automation In Drug Discovery Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lab Automation In Drug Discovery Market

9.1. China Lab Automation In Drug Discovery Market Overview
9.2. China Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lab Automation In Drug Discovery Market

10.1. India Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lab Automation In Drug Discovery Market

11.1. Japan Lab Automation In Drug Discovery Market Overview
11.2. Japan Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lab Automation In Drug Discovery Market

12.1. Australia Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lab Automation In Drug Discovery Market

13.1. Indonesia Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lab Automation In Drug Discovery Market

14.1. South Korea Lab Automation In Drug Discovery Market Overview
14.2. South Korea Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lab Automation In Drug Discovery Market

15.1. Western Europe Lab Automation In Drug Discovery Market Overview
15.2. Western Europe Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lab Automation In Drug Discovery Market

16.1. UK Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lab Automation In Drug Discovery Market

17.1. Germany Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lab Automation In Drug Discovery Market

18.1. France Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lab Automation In Drug Discovery Market

19.1. Italy Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lab Automation In Drug Discovery Market

20.1. Spain Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lab Automation In Drug Discovery Market

21.1. Eastern Europe Lab Automation In Drug Discovery Market Overview
21.2. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lab Automation In Drug Discovery Market

22.1. Russia Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lab Automation In Drug Discovery Market

23.1. North America Lab Automation In Drug Discovery Market Overview
23.2. North America Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lab Automation In Drug Discovery Market

24.1. USA Lab Automation In Drug Discovery Market Overview
24.2. USA Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lab Automation In Drug Discovery Market

25.1. Canada Lab Automation In Drug Discovery Market Overview
25.2. Canada Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lab Automation In Drug Discovery Market

26.1. South America Lab Automation In Drug Discovery Market Overview
26.2. South America Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lab Automation In Drug Discovery Market

27.1. Brazil Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lab Automation In Drug Discovery Market

28.1. Middle East Lab Automation In Drug Discovery Market Overview
28.2. Middle East Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lab Automation In Drug Discovery Market

29.1. Africa Lab Automation In Drug Discovery Market Overview
29.2. Africa Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lab Automation In Drug Discovery Market Competitive Landscape And Company Profiles

30.1. Lab Automation In Drug Discovery Market Competitive Landscape
30.2. Lab Automation In Drug Discovery Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Abbott Diagnostics
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Roche Holdings Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Beckman Coulter
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Siemens Healthineers
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Lab Automation In Drug Discovery Market Other Major And Innovative Companies

31.1. Becton Dickinson and Company
31.2. Agilent Technologies Inc.
31.3. PerkinElmer Inc.
31.4. Endress+Hauser
31.5. Shimadzu Corporation
31.6. Waters Corporation
31.7. Bio-Rad Laboratories Inc.
31.8. QIAGEN
31.9. Beckhoff Automation GmbH & Co. KG
31.10. Eppendorf AG
31.11. Tecan Group Ltd.
31.12. Brooks Automation Inc.
31.13. Hamilton Company
31.14. AbCellera Biologics Inc.
31.15. Hudson Robotics Inc.

32. Global Lab Automation In Drug Discovery Market Competitive Benchmarking

33. Global Lab Automation In Drug Discovery Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lab Automation In Drug Discovery Market

35. Lab Automation In Drug Discovery Market Future Outlook and Potential Analysis

35.1 Lab Automation In Drug Discovery Market In 2028 - Countries Offering Most New Opportunities
35.2 Lab Automation In Drug Discovery Market In 2028 - Segments Offering Most New Opportunities
35.3 Lab Automation In Drug Discovery Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer